Archives
-
Tetraethylammonium chloride K+ Channel Assays
2026-09-20
Tetraethylammonium chloride (TEAC) offers a practical way to interrogate potassium-channel pore conduction, mutant-channel behavior, and vascular responses. This workflow connects TEAC pharmacology with 86Rb efflux, patch-clamp, insulin-release, and isolated-artery assays while emphasizing controls that prevent receptor and ion-channel mechanisms from being confused.
-
Mecamylamine Hydrochloride as a Circuit Probe
2026-09-19
Mecamylamine hydrochloride can turn broad cholinergic observations into testable receptor-level hypotheses. This article presents a confound-aware framework for applying mecamylamine to gut–brain, seizure, and neuropsychiatric disorder research.
-
Amikacin (BAY416651) Resistance Workflows
2026-09-18
Amikacin (BAY416651) supports more than routine susceptibility testing: it can connect bacterial protein synthesis inhibition with enzyme-specific resistance, plasmid localization, and transmission assays. This research-focused workflow combines practical stock handling with the molecular framework used to study carbapenem-resistant Enterobacter cloacae.
-
Verapamil in Hypoxia-Driven Inflammation
2026-09-18
Verapamil ((±)-Verapamil) provides a practical perturbation tool for testing how prolonged hypoxia engages the ROS/TXNIP/NLRP3 axis in urothelial cells. This guide translates the reference findings into an executable workflow while highlighting controls for calcium-channel, P-glycoprotein, solvent, and exposure-time confounding.
-
Lamotrigine: Sodium Channel Research Guide
2026-09-17
Lamotrigine is a high-purity sodium channel blocker research compound identified as 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine. Its reported 5-HT activity, solubility profile, and compatibility with neuronal and cardiomyocyte assays support controlled epilepsy and cardiac sodium current modulation studies.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-09-17
A 2024 bioRxiv preprint identifies CLCC1 as an essential host factor for the membrane-fusion step of herpesvirus nuclear egress, linking viral capsid release to nuclear-envelope morphogenesis. Its CRISPR-screen and cell-biology findings provide a framework for distinguishing viral budding defects from post-budding fusion defects, while remaining subject to the limitations of an unreviewed study.
-
Tetrandrine: From Ion Channels to Assay Design
2026-09-16
Tetrandrine research spans calcium-channel biology, inflammation, neuroscience, and cancer models. This evidence-led guide shows how to connect membrane pharmacology with structure-based screening while avoiding overinterpretation of computational findings.
-
Psora 4: Interpreting Kv1.3 Blockade in T Cells
2026-09-16
Psora 4 is a selective Kv1.3 blocker for dissecting T-cell calcium signaling and effector-memory responses. This article explains how KCNE4-dependent channel architecture, endpoint timing, and cell-state controls can improve the interpretation of Psora 4 experiments.
-
NSP15 Inhibitor Screening: Thymopentin and Oleuropein
2026-09-15
A 2021 structure-based study screened a natural-product library against the SARS-CoV-2 NSP15 endoribonuclease and identified thymopentin and oleuropein as the highest-ranked candidates. Molecular dynamics simulations supported stable protein–ligand complexes, but the findings remain computational and require biochemical, cellular, and infection-model validation.
-
Methylprednisolone Sodium Succinate Workflows
2026-09-15
Build concentration-aware workflows for cytokine suppression, oxidative-burst testing, and apoptosis induction in tumor cells with a research-grade synthetic corticosteroid. This guide connects product handling with assay controls, translational interpretation, and practical troubleshooting for inflammation and immunology studies.
-
DIDS: Workflow for Channel and Tumor Assays
2026-09-14
DIDS connects chloride-transport pharmacology with vascular, sensory, neuroprotection, and near-death tumor-cell workflows. This guide emphasizes formulation control, matched controls, and assay designs that separate broad anion-transport effects from pathway-specific biology.
-
Dasatinib Monohydrate in Tumor Assembloids
2026-09-14
Use Dasatinib Monohydrate as a pathway-resolved kinase probe in matched gastric tumor organoids and stromal assembloids, not simply as a cytotoxicity reagent. This workflow separates epithelial sensitivity from microenvironment-mediated resistance while extending BMS-354825 research into patient-specific models.
-
From Reporter Signal to mRNA Platform Strategy
2026-09-13
Reporter mRNA is more than a fluorescence reagent: it is a practical calibration layer for separating delivery, intracellular stability, innate sensing, and translation. This article examines how EZ Cap™ EGFP mRNA (5-moUTP) can support mechanistic assay design and translational decisions, while connecting its architecture to emerging advances in mRNA loading and lipid nanoparticle engineering.
-
Tetrandrine: From Calcium Signals to Translation
2026-09-12
A translational framework for using the Tetrandrine alkaloid as a mechanistic perturbation tool in calcium signaling, inflammation, neuroscience, and cancer biology, while separating established pharmacology from computational antiviral hypotheses.
-
Propranolol and Essential Tremor: TMS Mechanisms
2026-09-11
A 2024 prospective observational study used transcranial magnetic stimulation and eyeblink classical conditioning to distinguish how primidone and propranolol affect essential tremor circuits. The findings associate propranolol response with reduced corticospinal excitability and increased short afferent inhibition, supporting a central noradrenergic–GABAergic contribution alongside established peripheral β-adrenergic actions.